Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) EBIT: ₺ Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ORZAX Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
18 GF Score
Price ₺87.50
! 3 Warning Signs
View Full Analysis

What is Orzaks Ilac Ve Kimyanayi Ticaret AS EBIT?

Orzaks Ilac Ve Kimyanayi Ticaret AS IST:ORZAX -1.41% 18 EBIT is ₺ Mil as of Dec. 2025. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Orzaks Ilac Ve Kimyanayi Ticaret AS's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was ₺2,489 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Orzaks Ilac Ve Kimyanayi Ticaret AS's annualized ROC % for the quarter that ended in Dec. 2025 was 29.29%. Orzaks Ilac Ve Kimyanayi Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 72.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Orzaks Ilac Ve Kimyanayi Ticaret AS  (IST:ORZAX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Orzaks Ilac Ve Kimyanayi Ticaret AS's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=2510.547 * ( 1 - 32.45% )/( (4152.821 + 7425.955)/ 2 )
=1695.8744985/5789.388
=29.29 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5522.996 - 739.432 - ( 630.743 - max(0, 2489.993 - 4599.303+630.743))
=4152.821

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8819.958 - 1070.043 - ( 323.96 - max(0, 4263.304 - 7658.669+323.96))
=7425.955

Note: The Operating Income data used here is one times the annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Orzaks Ilac Ve Kimyanayi Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2489.431/( ( (787.27 + max(1733.997, 0)) + (928.114 + max(3398.275, 0)) )/ 2 )
=2489.431/( ( 2521.267 + 4326.389 )/ 2 )
=2489.431/3423.828
=72.71 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1504.937 + 988.437 + 293.646) - (739.432 + 0 + 313.591)
=1733.997

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2455.385 + 1345.698 + 1068.98) - (1070.043 + 0 + 401.745)
=3398.275

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Orzaks Ilac Ve Kimyanayi Ticaret AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=/30239.474
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orzaks Ilac Ve Kimyanayi Ticaret AS EBIT Related Terms

Orzaks Ilac Ve Kimyanayi Ticaret AS EBIT Historical Data

* Premium members only.

The historical data trend for Orzaks Ilac Ve Kimyanayi Ticaret AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orzaks Ilac Ve Kimyanayi Ticaret AS EBIT Chart

Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend Dec23 Dec24 Dec25
EBIT
1,707.21 1,702.39 2,489.43

Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23 Dec24 Dec25
EBIT 1,707.21 1,702.39 2,489.43

IST:ORZAX vs KHC, GIS: EBIT Comparison

For the Packaged Foods subindustry, Orzaks Ilac Ve Kimyanayi Ticaret AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orzaks Ilac Ve Kimyanayi Ticaret AS EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Orzaks Ilac Ve Kimyanayi Ticaret AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Orzaks Ilac Ve Kimyanayi Ticaret AS's EV-to-EBIT falls into.


IST:ORZAX
18GF Score
Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orzaks Ilac Ve Kimyanayi Ticaret AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was ₺ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₺ Mil mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a EBIT of ₺ Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's EBIT too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current EBIT is ₺ Mil. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's EBIT compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's EBIT of ₺ Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS. Orzaks Ilac Ve Kimyanayi Ticaret AS's current EBIT is ₺ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current EBIT of ₺ Mil. The current EBIT is ₺ Mil. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current EBIT is ₺ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orzaks Ilac Ve Kimyanayi Ticaret AS Business Description

Address Esentepe Mah, Buyukdere Cad, No:171, Metrocity Is Merkezi A Blok Kat:1, Sisli, Istanbul, TUR
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score

Get the complete analysis for IST:ORZAX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺87.50
Price